216 related articles for article (PubMed ID: 19052516)
21. Treatment options for venous leg ulcers: effectiveness of vascular surgery, bioengineered tissue, and electrical stimulation.
Thakral G; La Fontaine J; Kim P; Najafi B; Nichols A; Lavery LA
Adv Skin Wound Care; 2015 Apr; 28(4):164-72. PubMed ID: 25775200
[TBL] [Abstract][Full Text] [Related]
22. The Wound Healing Society chronic wound ulcer healing guidelines update of the 2006 guidelines--blending old with new.
Kirsner RS
Wound Repair Regen; 2016; 24(1):110-1. PubMed ID: 26663573
[No Abstract] [Full Text] [Related]
23. Visible light-induced healing of diabetic or venous foot ulcers: a placebo-controlled double-blind study.
Landau Z; Migdal M; Lipovsky A; Lubart R
Photomed Laser Surg; 2011 Jun; 29(6):399-404. PubMed ID: 21214497
[TBL] [Abstract][Full Text] [Related]
24. [Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent].
Ramelet AA; Debure C; Lok C; Meaume S; Guilhou JJ; Senet P
Ann Dermatol Venereol; 1999 Apr; 126(4):380-4. PubMed ID: 10421949
[No Abstract] [Full Text] [Related]
25. Allogeneic Skin Substitutes Versus Human Placental Membrane Products in the Management of Diabetic Foot Ulcers: A Narrative Comparative Evaluation of the Literature.
Luck J; Rodi T; Geierlehner A; Mosahebi A
Int J Low Extrem Wounds; 2019 Mar; 18(1):10-22. PubMed ID: 30663450
[TBL] [Abstract][Full Text] [Related]
26. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
27. Systematic review of hyperbaric oxygen in the management of chronic wounds.
Roeckl-Wiedmann I; Bennett M; Kranke P
Br J Surg; 2005 Jan; 92(1):24-32. PubMed ID: 15635604
[TBL] [Abstract][Full Text] [Related]
28. The role of Apligraf in the treatment of venous leg ulcers.
Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J
Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970
[TBL] [Abstract][Full Text] [Related]
29. EpiDex® Swiss field trial 2004-2008.
Ortega-Zilic N; Hunziker T; Läuchli S; Mayer DO; Huber C; Baumann Conzett K; Sippel K; Borradori L; French LE; Hafner J
Dermatology; 2010; 221(4):365-72. PubMed ID: 21071921
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers.
Ananian CE; Dhillon YS; Van Gils CC; Lindsey DC; Otto RJ; Dove CR; Pierce JT; Saunders MC
Wound Repair Regen; 2018 May; 26(3):274-283. PubMed ID: 30098272
[TBL] [Abstract][Full Text] [Related]
31. [Cost-benefit analysis of amniotic membrane transplantation for venous ulcers of the legs that are refractory to conventional treatment].
Gutiérrez-Moreno S; Alsina-Gibert M; Sampietro-Colom L; Pedregosa-Fauste S; Ayala-Blanco P
Actas Dermosifiliogr; 2011 May; 102(4):284-8. PubMed ID: 21440240
[TBL] [Abstract][Full Text] [Related]
32. [Leg and foot ulcers. Rapid healing and reduced number of amputations with improved treatment].
Brismar K; Beitner H; Swedenborg J
Lakartidningen; 1993 Nov; 90(47):4216-21. PubMed ID: 8255134
[No Abstract] [Full Text] [Related]
33. Skin Structure-Function Relationships and the Wound Healing Response to Intrinsic Aging.
Blair MJ; Jones JD; Woessner AE; Quinn KP
Adv Wound Care (New Rochelle); 2020 Mar; 9(3):127-143. PubMed ID: 31993254
[No Abstract] [Full Text] [Related]
34. Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia.
Marston WA;
Ostomy Wound Manage; 2006 Mar; 52(3):26-8, 30, 32 passim. PubMed ID: 16567857
[TBL] [Abstract][Full Text] [Related]
35. The Economic Impact of Living Cell Tissue Products in Treating Diabetic Foot Ulcers and Venous Leg Ulcers in Patients with Commercial Insurance: A Retrospective Matched-Cohort Study.
Barbul A; Gelly H; Obradovic K; Landsman A
Adv Skin Wound Care; 2023 May; 36(5):243-248. PubMed ID: 37079787
[TBL] [Abstract][Full Text] [Related]
36. Initial Reduction in Ulcer Size As a Prognostic Indicator for Complete Wound Healing: A Systematic Review of Diabetic Foot and Venous Leg Ulcers.
Gwilym BL; Mazumdar E; Naik G; Tolley T; Harding K; Bosanquet DC
Adv Wound Care (New Rochelle); 2023 Jun; 12(6):327-338. PubMed ID: 35343244
[No Abstract] [Full Text] [Related]
37. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers.
Carter MJ; Waycaster C; Schaum K; Gilligan AM
Value Health; 2014 Dec; 17(8):801-13. PubMed ID: 25498775
[TBL] [Abstract][Full Text] [Related]
38. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study.
Lullove EJ
Wounds; 2017 Apr; 29(4):107-114. PubMed ID: 28448264
[TBL] [Abstract][Full Text] [Related]
39. A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers.
Stone RC; Stojadinovic O; Sawaya AP; Glinos GD; Lindley LE; Pastar I; Badiavas E; Tomic-Canic M
Wound Repair Regen; 2020 Mar; 28(2):164-176. PubMed ID: 31674093
[TBL] [Abstract][Full Text] [Related]
40. Exercise and Chronic Wound Healing.
Bolton L
Wounds; 2019 Feb; 31(2):65-67. PubMed ID: 30694211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
